Delivery Order SPE2DB22D1200-SPE2DB24FN2FA
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $5,716.50 firm-fixed-price delivery order is for the supply of 1,440 units/ml of the HAVRIX vaccine. The contract has an ultimate completion date of July 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of prescription medications, over-the-counter drugs, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $4,703.76, is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a completion date of September 13, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. government, holding...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,732.50 firm fixed-price delivery order is for the supply of HAVRIX 720 UNIT/0.5 ML syringes. The contract has an ultimate completion date of October 2, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,821,991 units of the pharmaceutical product HAVRIX 1,440 UNIT/ML SYRINGE. The $14,901.12 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 6, 2024 with a completion date of June 7, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, particularly the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Havrix vaccines in a Firm Fixed Price Delivery Order contract valued at $1,315.23. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen, through its Corporate Office Division, is a large supplier of pharmaceutical products and medical supplies to various government agencies, particularly supporting the...
- This federal contract award is for the supply of HAVRIX 1,440 unit/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and is a non-set-aside delivery order with a firm fixed price of $1,201.60. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $3,735.05 firm fixed price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of HAVRIX 1,440 unit/mL syringe medical supplies. The contract has a ceiling value of $2,420.70 and runs through February 10, 2025, with a firm fixed price pricing type. The award is from the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,959.90 firm fixed-price delivery order is for the supply of HAVRIX 720 Unit/0.5 ML syringes, which are a type of pharmaceutical product. The contract has an ultimate completion date of May 30, 2024. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,769.15 firm fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, which are likely vaccines or other medical supplies. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB24FN2FADelivery Order
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $21,214.10, is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, for the provision of HAVRIX 1,440 UNIT/ML SYRINGEML. The contract has a Firm Fixed Price pricing type and an Ultimate Completion Date of May 2, 2024. The award does not have a Set-Aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 5/1/24 |